Latest Retro Bio News & Updates

See the latest news and media coverage for Retro. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Retro Bio (Retro)

Developer of therapeutics targeting cellular aging

retro.bio
Headquarters
Redwood City, United States
Company type
Private company
Number of employees
90–200

Latest news about Retro Bio (Retro)

Company announcements

  • Retro

    Retro achieves First In Human milestone

    Retro becomes a clinical stage company after reaching the clinic in Q4. The organization thanks teams and anticipates 2026.

  • Retro

    Retro Bio highlights collaboration with OpenAI on GPT-4b

    The partnership focuses on using GPT-4b to engineer proteins that enhance stem cell reprogramming and accelerate their mission.

  • Retro

    Retro Bio announces collaboration with MCRI

    The partnership aims to develop preventative medicine by rejuvenating the blood system using a person's genetics to extend healthy lifespan by 10 years.

  • Retro

    Retro Bio partners with MCRI for blood disorder therapies

    The collaboration combines MCRI's stem cell breakthroughs with Retro Bio's biotechnology to develop regenerative solutions for longer, healthier lives.

Unlock all announcements with a

Media coverage

  • Scientific American

    This method to reverse cellular aging is about to be tested in humans

    A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

  • Nature

    This method to reverse cellular ageing is about to be tested in humans

    A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely refresh aged tissues and organs.

  • Longevity.Technology

    Retro Bio commences first-in-human trial

    Autophagy-enhancing drug candidate enters Phase 1 trial as longevity focused biotech eyes Alzheimer's as a potential first indication.

  • corememory.com

    Exclusive: Retro Hopes It Has Found A New Way To Combat Alzheimer's Disease

    Almost three years ago, the world learned that OpenAI CEO Sam Altman had put a staggering $180 million into a longevity start-up called Retro Bio...

Unlock all articles with a

Never miss news about Retro

Track Retro and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Retro competitors & trending companies

Browse news for competitors to Retro and other trending companies.